|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.04 USD | -1.38% |
|
-2.97% | +213.33% |
May 20 (Reuters) - Hedge fund Shah Capital said on Monday that it was withdrawing its preliminary proxy statement and its campaign against the re-election of three directors on Novavax's board.
Shah Capital owns an about 7.8% stake in the COVID-19 vaccine maker, according to a regulatory filing on Monday. (Reporting by Bhanvi Satija in Bengaluru; Editing by Shilpi Majumdar)
| 1st Jan change | Capi. | |
|---|---|---|
| +213.33% | 2.11B | |
| +43.36% | 54.63B | |
| -5.31% | 39.92B | |
| +14.75% | 26.86B | |
| -12.56% | 26.22B | |
| -22.45% | 18.78B | |
| +25.12% | 12.21B | |
| +0.04% | 12.16B | |
| +26.04% | 11.94B | |
| -11.83% | 10.74B |
NOVAVAX, INC. 
